• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于基因递送的刺激响应性非病毒纳米颗粒

Stimuli-Responsive Non-viral Nanoparticles for Gene Delivery.

作者信息

Reichel Liên S, Traeger Anja

机构信息

Institute of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena, Jena, Germany.

Jena Center for Soft Matter (JCSM), Friedrich Schiller University Jena, Jena, Germany.

出版信息

Handb Exp Pharmacol. 2024;284:27-43. doi: 10.1007/164_2023_694.

DOI:10.1007/164_2023_694
PMID:37644142
Abstract

Considering nucleic acids as the language of life and the genome as the instruction manual of cells, their targeted modulation promises great opportunities in treating and healing diseases. In addition to viral gene transfer, the overwhelming power of non-viral mRNA-based vaccines is driving the development of novel gene transporters. Thereby, various nucleic acids such as DNA (pDNA) or RNA (mRNA, siRNA, miRNA, gRNA, or ASOs) need to be delivered, requiring a transporter due to their high molar mass and negative charge in contrast to classical agents. This chapter presents the specific biological hurdles for using nucleic acids and shows how new materials can overcome these.

摘要

将核酸视为生命的语言,基因组视为细胞的说明书,对它们进行靶向调控有望为疾病治疗和治愈带来巨大机遇。除了病毒基因传递外,基于非病毒信使核糖核酸的疫苗的强大作用正在推动新型基因转运体的发展。因此,需要递送各种核酸,如脱氧核糖核酸(pDNA)或核糖核酸(mRNA、小干扰核糖核酸、微小核糖核酸、引导核糖核酸或反义寡核苷酸),与传统药物相比,由于它们的高摩尔质量和负电荷,需要一种转运体。本章介绍了使用核酸时面临的具体生物学障碍,并展示了新材料如何克服这些障碍。

相似文献

1
Stimuli-Responsive Non-viral Nanoparticles for Gene Delivery.用于基因递送的刺激响应性非病毒纳米颗粒
Handb Exp Pharmacol. 2024;284:27-43. doi: 10.1007/164_2023_694.
2
Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing.CRISPR/Cas 在体内基因组编辑中的传递方面。
Acc Chem Res. 2019 Jun 18;52(6):1555-1564. doi: 10.1021/acs.accounts.9b00106. Epub 2019 May 17.
3
Recent Advances and Challenges in Gene Delivery Mediated by Polyester-Based Nanoparticles.聚酯纳米载体介导的基因传递的最新进展和挑战。
Int J Nanomedicine. 2021 Aug 31;16:5981-6002. doi: 10.2147/IJN.S321329. eCollection 2021.
4
CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination.CRISPR-Cas9 介导的外显子干扰用于 HIV-1 的清除。
EBioMedicine. 2021 Nov;73:103678. doi: 10.1016/j.ebiom.2021.103678. Epub 2021 Nov 10.
5
Cell-Selective Messenger RNA Delivery and CRISPR/Cas9 Genome Editing by Modulating the Interface of Phenylboronic Acid-Derived Lipid Nanoparticles and Cellular Surface Sialic Acid.通过调节苯硼酸衍生脂质纳米颗粒与细胞表面唾液酸的界面实现细胞选择性信使 RNA 传递和 CRISPR/Cas9 基因组编辑。
ACS Appl Mater Interfaces. 2019 Dec 18;11(50):46585-46590. doi: 10.1021/acsami.9b17749. Epub 2019 Dec 9.
6
Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.用于细胞内 mRNA 递送和基因组编辑的可生物降解脂质纳米粒子的开发。
Acc Chem Res. 2021 Nov 2;54(21):4001-4011. doi: 10.1021/acs.accounts.1c00500. Epub 2021 Oct 20.
7
Role of Lipid-Based and Polymer-Based Non-Viral Vectors in Nucleic Acid Delivery for Next-Generation Gene Therapy.脂质体和聚合物非病毒载体在下一代基因治疗中的核酸传递中的作用。
Molecules. 2020 Jun 22;25(12):2866. doi: 10.3390/molecules25122866.
8
Development of ionizable lipid nanoparticles and a lyophilized formulation for potent CRISPR-Cas9 delivery and genome editing.可电离脂质纳米颗粒及冻干制剂的研发,用于高效递送CRISPR-Cas9并进行基因组编辑。
Int J Pharm. 2024 Mar 5;652:123845. doi: 10.1016/j.ijpharm.2024.123845. Epub 2024 Jan 22.
9
Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.基因治疗与 CRISPR/Cas9 渐趋成熟,有望攻克 HIV。
AIDS Rev. 2017 Oct-Dec;19(3):167-172.
10
Polymers for nucleic acid transfer-an overview.用于核酸转移的聚合物——综述
Adv Genet. 2014;88:231-61. doi: 10.1016/B978-0-12-800148-6.00008-0.

引用本文的文献

1
Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery.精准纳米医学:探索肿瘤微环境以增强癌症免疫治疗和靶向药物递送
Mol Cancer. 2025 Jun 3;24(1):160. doi: 10.1186/s12943-025-02357-z.
2
mRNA Delivery: Challenges and Advances through Polymeric Soft Nanoparticles.mRNA 递送:通过聚合物软纳米颗粒的挑战与进展。
Int J Mol Sci. 2024 Feb 1;25(3):1739. doi: 10.3390/ijms25031739.

本文引用的文献

1
RNA modifications: importance in immune cell biology and related diseases.RNA 修饰:在免疫细胞生物学和相关疾病中的重要性。
Signal Transduct Target Ther. 2022 Sep 22;7(1):334. doi: 10.1038/s41392-022-01175-9.
2
Directing the Way-Receptor and Chemical Targeting Strategies for Nucleic Acid Delivery.导向-受体与化学靶向策略在核酸递送中的应用。
Pharm Res. 2023 Jan;40(1):47-76. doi: 10.1007/s11095-022-03385-w. Epub 2022 Sep 15.
3
Nanodelivery of nucleic acids.核酸的纳米递送
Nat Rev Methods Primers. 2022;2. doi: 10.1038/s43586-022-00104-y. Epub 2022 Apr 14.
4
Drug delivery systems for RNA therapeutics.RNA 治疗药物的递药系统。
Nat Rev Genet. 2022 May;23(5):265-280. doi: 10.1038/s41576-021-00439-4. Epub 2022 Jan 4.
5
Zwitterionic Phospholipidation of Cationic Polymers Facilitates Systemic mRNA Delivery to Spleen and Lymph Nodes.两性离子磷脂化阳离子聚合物有助于系统递送 mRNA 至脾脏和淋巴结。
J Am Chem Soc. 2021 Dec 22;143(50):21321-21330. doi: 10.1021/jacs.1c09822. Epub 2021 Dec 8.
6
The tangled history of mRNA vaccines.信使核糖核酸疫苗的复杂历史。
Nature. 2021 Sep;597(7876):318-324. doi: 10.1038/d41586-021-02483-w.
7
Lipids and Lipid Derivatives for RNA Delivery.用于 RNA 递送的脂质和脂质衍生物。
Chem Rev. 2021 Oct 27;121(20):12181-12277. doi: 10.1021/acs.chemrev.1c00244. Epub 2021 Jul 19.
8
The current landscape of nucleic acid therapeutics.核酸疗法的现状。
Nat Nanotechnol. 2021 Jun;16(6):630-643. doi: 10.1038/s41565-021-00898-0. Epub 2021 May 31.
9
Advances in oligonucleotide drug delivery.寡核苷酸药物递送的进展。
Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11.
10
Opportunities, Barriers, and a Strategy for Overcoming Translational Challenges to Therapeutic Nucleic Acid Nanotechnology.治疗性核酸纳米技术转化面临的机遇、障碍及克服转化挑战的策略
ACS Nano. 2020 Aug 25;14(8):9221-9227. doi: 10.1021/acsnano.0c04753. Epub 2020 Jul 24.